EPECEPECEPECEPEC EPECEPECEPECEPEC Common Physical Symptoms Common Physical Symptoms Module 10 The Project to Educate Physicians on End-of-life Care.

Slides:



Advertisements
Similar presentations
Constipation and the Cancer Patient
Advertisements

Management Of Nausea and Vomiting in Palliative Care
Common Physical Symptoms at the End of Life: Pulmonary and GI Symptoms Mike Marschke, MD.
EPECEPECEPECEPEC EPECEPECEPECEPEC Withholding, Withdrawing Therapy Withholding, Withdrawing Therapy Module 11 The Project to Educate Physicians on End-of-life.
EPECEPECEPECEPEC American Osteopathic Association AOA: Treating our Family and Yours Osteopathic EPEC Osteopathic EPEC Education for Osteopathic Physicians.
End of Life Curriculum Project-Lunchtime symposia for M1 & M2 Daniel McFarland NYCOM 2004.
Prof. Hanan Hagar Pharmacology Department College of Medicine
Drugs acting on the Gastrointestinal Tract:- Gastrointestinal diseases is a common clinical problem in veterinary practice, and accurate diagnosis is essential.
EPECEPECEPECEPEC EPECEPECEPECEPEC Module 11 Withholding, Withdrawing Life- Sustaining Treatments The Education in Palliative and End-of-life Care program.
EPE C for VE T E R A N S EPE C for VE T E R A N S Education in Palliative and End-of-life Care for Veterans is a collaborative effort between the Department.
Constipation and Diarrhea Elizabeth Whiteman M.D..
PTP 546 Module 12: Gastrointestinal Pharmacology Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
Constipation Definition *is adecrease in the frequency of fecal elimenation *hard / dry and somtime painfull stools *normal stool range from three time.
Nausea and Vomiting James Hallenbeck, MD Director, Palliative Care Services, Palo Alto VAHCS, Stanford University.
To prevent and relieve suffering, and promote quality of life at every stage of life.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Department of Pharmacology
EPECEPECEPECEPEC EPECEPECEPECEPEC Last Hours of Living Module 12 The Education in Palliative and End-of-life Care program at Northwestern University Feinberg.
EPECEPECEPECEPEC EPECEPECEPECEPEC Depression, Anxiety, Delirium Depression, Anxiety, Delirium Module 6 The Project to Educate Physicians on End-of-life.
EPECEPECEPECEPEC American Osteopathic Association AOA: Treating Our Family and Yours Osteopathic EPEC Osteopathic EPEC Education for Osteopathic Physicians.
Nausea and Vomiting in Palliative Care Elizabeth Whiteman M.D.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 51 Antiemetic and Antinausea Agents.
MANAGING FATIGUE during treatment Since fatigue is the most common symptom in people receiving chemotherapy, patients should learn ways to manage the fatigue.
Drugs for Treating GI Disorders Chapter 11. GI Disorders  Peptic Ulcer and Acid Reflux Disorders  Laxatives and Cathartics  Antidiarrheals  Antiemetics.
EPE C for VE T E R A N S EPE C for VE T E R A N S Education in Palliative and End-of-life Care for Veterans is a collaborative effort between the Department.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Evaluation and Treatment of Nausea and Vomiting
EPECEPECEPECEPEC EPECEPECEPECEPEC Constitutional Symptoms Module 10b The Education in Palliative and End-of-life Care program at Northwestern University.
Drugs Acting on the Gastrointestinal Tract. 1.Emetics and Antiemetics.
CARE OF DYING PATIENT Dorothy D. Sherwood, M.D. 6/11/2005.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Digestants & Drugs Affecting Gallbladder Promote the process of digestion in GI tract pancrealipase (Pancrease) - contains digestive enzymes Side effect:
Objectives Have a better understanding of how physical and mental factors affect symptomatology Be able to use this understanding in the treatment of patients.
The Basics of Symptom Management: Understanding, Assessment and Principles Dr. Leah Steinberg.
End of Life Symptom Management Dec 3, 2014 Mudit Dabral Rosene Pirrello.
Gastrointestinal Pharmacology

EPECEPECEPECEPEC GI Symptoms Module 10a The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School of Medicine,
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 53 Antiemetic and Antinausea Drugs.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
EPECEPECEPECEPEC EPECEPECEPECEPEC Dyspnea Module 10c The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School.
GI Diseases Review 30 November :04 AM.
Laxative and anti-diarrheal
Mual Muntah Afifah Machlaurin>. Siapkan kertas Sebutkan titik yang bertanggung jawab terhadap respon mualmuntah ! 2. Sebutkan 4 mekanisme stimulasi.
Drugs Used to Treat Nausea and Vomiting Chapter 34 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Laxatives and Antidiarrheals
Chapter 25 Emetics and Antiemetics. Emetics p585 Agents that induce vomiting – Used in overdoses Example – Ipecac syrup Inappropriate use of emetics –
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Peptic ulcers are open sores in the mucosa of the lower oesophagus (esophageal ulcer), duodenum (dudenal ulcer ) and stomach (gastric ulcers). Caused.
Palliative Care: Non pain symptoms Elizabeth Whiteman, M.D.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Management Of Nausea And Vomiting In Palliative Care
What is Palliative Care? n Support and comfort for individuals and families living with chronic or life- threatening illnesses n Focuses on: –Relieving.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Chapter 33 Therapy of Gastrointestinal Disorders: Peptic Ulcers, GERD, and Vomiting.
Jeopardy Final Jeopardy Antacids Antiemetics/ Emetics $100 $100 $100
Assistant Professor Dr. Shamil AL-Neaimy
Supportive and Palliative Care Pharmacology Toolkit for Non-Pain Symptom Management Shirley Brogley March 24, 2017.

Nausea, Vomiting & Constipation
HAVE YOU EVER….
Drugs Used to Treat Constipation and Diarrhea
Jeffrey Kendall, Psy.D. Director, Oncology Supportive Care
PALLIATIVE MEDICINE NAUSEA, VOMITING, BOWEL OBSTRUCTION
Other Gastrointestinal Drugs
DRUGS FOR GI DISORDERS CHAPTER 8. GI Disorders COMMON DISEASES OF GI SYTEM INCLUDES Peptic Ulcer and Acid Reflux Disorders Laxatives and Cathartics.
Presentation transcript:

EPECEPECEPECEPEC EPECEPECEPECEPEC Common Physical Symptoms Common Physical Symptoms Module 10 The Project to Educate Physicians on End-of-life Care Supported by the American Medical Association and the Robert Wood Johnson Foundation

Objectives l Know general guidelines for managing nonpain symptoms l Understand how the principles of intended / unintended consequences and double effect apply to symptom management l Know the assessment, management of common physical symptoms l Know general guidelines for managing nonpain symptoms l Understand how the principles of intended / unintended consequences and double effect apply to symptom management l Know the assessment, management of common physical symptoms

General management guidelines... l History, physical examination l Conceptualize likely causes l Discuss treatment options, assist with decision making l History, physical examination l Conceptualize likely causes l Discuss treatment options, assist with decision making

... General management guidelines l Provide ongoing patient, family education, support l Involve members of the entire interdisciplinary team l Reassess frequently l Provide ongoing patient, family education, support l Involve members of the entire interdisciplinary team l Reassess frequently

Intended vs unintended consequences l Primary intent dictates ethical medical practice

Breathlessness (dyspnea)... l May be described as shortness of breath a smothering feeling inability to get enough air suffocation l May be described as shortness of breath a smothering feeling inability to get enough air suffocation

... Breathlessness (dyspnea) l The only reliable measure is patient self-report l Respiratory rate, pO 2, blood gas determinations DO NOT correlate with the feeling of breathlessness l Prevalence in the life-threateningly ill: 12 – 74% l The only reliable measure is patient self-report l Respiratory rate, pO 2, blood gas determinations DO NOT correlate with the feeling of breathlessness l Prevalence in the life-threateningly ill: 12 – 74%

Causes of breathlessness l Anxiety l Airway obstruction l Bronchospasm l Hypoxemia l Pleural effusion l Pneumonia l Pulmonary edema l Anxiety l Airway obstruction l Bronchospasm l Hypoxemia l Pleural effusion l Pneumonia l Pulmonary edema l Pulmonary embolism l Thick secretions l Anemia l Metabolic l Family / financial / legal / spiritual / practical issues

Management of breathlessness l Treat the underlying cause l Symptomatic management oxygenopioidsanxiolytics nonpharmacologic interventions l Treat the underlying cause l Symptomatic management oxygenopioidsanxiolytics nonpharmacologic interventions

Oxygen l Pulse oximetry not helpful l Potent symbol of medical care l Expensive l Fan may do just as well l Pulse oximetry not helpful l Potent symbol of medical care l Expensive l Fan may do just as well

Opioids l Relief not related to respiratory rate l No ethical or professional barriers l Small doses l Central and peripheral action l Relief not related to respiratory rate l No ethical or professional barriers l Small doses l Central and peripheral action

Anxiolytics l Safe in combination with opioids lorazepam mg po q 1 h prn until settled then dose routinely q 4–6 h to keep settled l Safe in combination with opioids lorazepam mg po q 1 h prn until settled then dose routinely q 4–6 h to keep settled

Nonpharmacologic interventions... l Reassure, work to manage anxiety l Behavioral approaches, eg, relaxation, distraction, hypnosis l Limit the number of people in the room l Open window l Reassure, work to manage anxiety l Behavioral approaches, eg, relaxation, distraction, hypnosis l Limit the number of people in the room l Open window

Nonpharmacologic interventions... l Eliminate environmental irritants l Keep line of sight clear to outside l Reduce the room temperature l Avoid chilling the patient l Eliminate environmental irritants l Keep line of sight clear to outside l Reduce the room temperature l Avoid chilling the patient

... Nonpharmacologic interventions l Introduce humidity l Reposition elevate the head of the bed move patient to one side or other l Educate, support the family l Introduce humidity l Reposition elevate the head of the bed move patient to one side or other l Educate, support the family

Nausea / vomiting l Nausea subjective sensation stimulation gastrointestinal lining, CTZ, vestibular apparatus, cerebral cortex l Vomiting neuromuscular reflex l Nausea subjective sensation stimulation gastrointestinal lining, CTZ, vestibular apparatus, cerebral cortex l Vomiting neuromuscular reflex

Causes of nausea / vomiting l Metastases l Meningeal irritation l Movement l Mental anxiety l Medications l Mucosal irritation l Metastases l Meningeal irritation l Movement l Mental anxiety l Medications l Mucosal irritation l Mechanical obstruction l Motility l Metabolic l Microbes l Myocardial

Pathophysiology of nausea / vomiting CortexCortex Vestibular apparatus GI tract Chemoreceptor Trigger Zone (CTZ) Neurotransmitters l Serotonin l Dopamine l Acetylcholine l Histamine Neurotransmitters l Serotonin l Dopamine l Acetylcholine l Histamine Vomiting center

Management of nausea / vomiting l Dopamine antagonists l Antihistamines l Anticholinergics l Serotonin antagonists l Dopamine antagonists l Antihistamines l Anticholinergics l Serotonin antagonists l Prokinetic agents l Antacids l Cytoprotective agents l Other medications

Dopamine antagonists l Haloperidol l Prochlorperazine l Droperidol l Thiethylperazine l Promethazine l Perphenazine l Trimethobenzamide l Metoclopramide l Haloperidol l Prochlorperazine l Droperidol l Thiethylperazine l Promethazine l Perphenazine l Trimethobenzamide l Metoclopramide

Histamine antagonists (antihistamines) l Diphenhydramine l Meclizine l Hydroxyzine l Diphenhydramine l Meclizine l Hydroxyzine

Acetylcholine antagonists (anticholinergics) l Scopolamine

Serotonin antagonists l Ondansetron l Granisetron l Ondansetron l Granisetron

Prokinetic agents l Metoclopramide l Cisapride l Metoclopramide l Cisapride

Antacids l Antacids l H 2 receptor antagonists cimetidinefamotidineranitidine l Proton pump inhibitors omeprazolelansoprazole l Antacids l H 2 receptor antagonists cimetidinefamotidineranitidine l Proton pump inhibitors omeprazolelansoprazole

Cytoprotective agents l Misoprostol l Proton pump inhibitors (omeprazole, lansoprazole) l Misoprostol l Proton pump inhibitors (omeprazole, lansoprazole)

Other medications l Dexamethasone l Tetrahydrocannabinol l Lorazepam l Octreotide l Dexamethasone l Tetrahydrocannabinol l Lorazepam l Octreotide

Constipation l Medications opioids calcium-channel blockers anticholinergic l Decreased motility l Ileus l Mechanical obstruction l Medications opioids calcium-channel blockers anticholinergic l Decreased motility l Ileus l Mechanical obstruction l Metabolic abnormalities l Spinal cord compression l Dehydration l Autonomic dysfunction l Malignancy

Management of constipation l General measures establish what is “normal” regular toileting gastrocolic reflex l General measures establish what is “normal” regular toileting gastrocolic reflex l Specific measures stimulantsosmoticsdetergentslubricants large volume enemas

Stimulant laxatives l Prune juice l Senna l Casanthranol l Bisacodyl l Prune juice l Senna l Casanthranol l Bisacodyl

Osmotic laxatives l Lactulose or sorbitol l Milk of magnesia (other Mg salts) l Magnesium citrate l Lactulose or sorbitol l Milk of magnesia (other Mg salts) l Magnesium citrate

Detergent laxatives (stool softeners) l Sodium docusate l Calcium docusate l Phosphosoda enema prn l Sodium docusate l Calcium docusate l Phosphosoda enema prn

Prokinetic agents l Metoclopramide l Cisapride l Metoclopramide l Cisapride

Lubricant stimulants l Glycerin suppositories l Oils mineralpeanut l Glycerin suppositories l Oils mineralpeanut

Large-volume enemas l Warm water l Soap suds l Warm water l Soap suds

Constipation from opioids... l Occurs with all opioids l Pharmacologic tolerance developed slowly, or not at all l Dietary interventions alone usually not sufficient l Avoid bulk-forming agents in debilitated patients l Occurs with all opioids l Pharmacologic tolerance developed slowly, or not at all l Dietary interventions alone usually not sufficient l Avoid bulk-forming agents in debilitated patients

... Constipation from opioids l Combination stimulant / softeners are useful first-line medications casanthranol + docusate sodium senna + docusate sodium l Prokinetic agents l Combination stimulant / softeners are useful first-line medications casanthranol + docusate sodium senna + docusate sodium l Prokinetic agents

Causes of diarrhea l Infections l GI bleeding l Malabsorption l Medications l Obstruction l Overflow incontinence l Stress l Infections l GI bleeding l Malabsorption l Medications l Obstruction l Overflow incontinence l Stress

Management of diarrhea l Establish normal bowel pattern l Avoid gas-forming foods l Increase bulk l Transient, mild diarrhea attapulgite bismuth salts l Establish normal bowel pattern l Avoid gas-forming foods l Increase bulk l Transient, mild diarrhea attapulgite bismuth salts

Management of persistent diarrhea l Loperamide l Diphenoxylate / atropine l Tincture of opium l Octreotide l Loperamide l Diphenoxylate / atropine l Tincture of opium l Octreotide

Anorexia / cachexia l Loss of appetite l Loss of weight l Loss of appetite l Loss of weight

Management of anorexia / cachexia... l Assess, manage comorbid conditions l Educate, support l Favorite foods / nutritional supplements l Assess, manage comorbid conditions l Educate, support l Favorite foods / nutritional supplements

... Management of anorexia / cachexia l Alcohol l Dexamethasone l Megestrol acetate l Tetrahydrocannabinol (THC) l Androgens l Alcohol l Dexamethasone l Megestrol acetate l Tetrahydrocannabinol (THC) l Androgens

Management of fatigue / weakness... l Promote energy conservation l Evaluate medications l Optimize fluid, electrolyte intake l Permission to rest l Clarify role of underlying illness l Educate, support patient, family l Include other disciplines l Promote energy conservation l Evaluate medications l Optimize fluid, electrolyte intake l Permission to rest l Clarify role of underlying illness l Educate, support patient, family l Include other disciplines

... Management of fatigue / weakness l Dexamethasone feeling of well-being, increased energy effect may wane after 4-6 weeks continue until death l Methylphenidate l Dexamethasone feeling of well-being, increased energy effect may wane after 4-6 weeks continue until death l Methylphenidate

Fluid balance / edema... l Frequently associated with advanced illness l Hypoalbuminemia  decreased oncotic pressure l Venous or lymphatic obstruction may contribute l Frequently associated with advanced illness l Hypoalbuminemia  decreased oncotic pressure l Venous or lymphatic obstruction may contribute

... Fluid balance / edema l Limit or avoid IV fluids l Urine output will be low l Drink some fluids with salt l Fragile skin l Limit or avoid IV fluids l Urine output will be low l Drink some fluids with salt l Fragile skin

Skin l Hygiene l Protection l Support l Hygiene l Protection l Support

Pressure (decubitus) ulcers l Prolonged pressure l Inactivity l Closely associated with mortality l Easier to prevent than treat l Prolonged pressure l Inactivity l Closely associated with mortality l Easier to prevent than treat

Odors l Topical and / or systemic antibiotics metronidazole silver sulfadiazine l Kitty litter l Activated charcoal l Vinegar l Burning candles l Topical and / or systemic antibiotics metronidazole silver sulfadiazine l Kitty litter l Activated charcoal l Vinegar l Burning candles

Insomnia l Assessment of sleep l Other unrelieved symptoms l Use family to help assess l Assessment of sleep l Other unrelieved symptoms l Use family to help assess

Management of insomnia... l Regular sleep schedule, avoid staying in bed l Avoid caffeine, assess alcohol intake l Cognitive / physical stimulation l Avoid overstimulation l Control pain during the night l Relaxation, imagery l Regular sleep schedule, avoid staying in bed l Avoid caffeine, assess alcohol intake l Cognitive / physical stimulation l Avoid overstimulation l Control pain during the night l Relaxation, imagery

... Management of insomnia l Antihistamines l Benzodiazepines l Neuroleptics l Sedating antidepressant (trazodone) l Careful titration l Attention to adverse effects l Antihistamines l Benzodiazepines l Neuroleptics l Sedating antidepressant (trazodone) l Careful titration l Attention to adverse effects

EPECEPECEPECEPEC EPECEPECEPECEPEC Common Physical Symptoms Summary Summary